Genotyping fetal paternally inherited SNPs by MALDI‐TOF MS using cell‐free fetal DNA in maternal plasma: Influence of size fractionation

Publisher Website
Google Scholar
Abstract
The determination of fetal point mutations from fetal cell‐free DNA (cf‐DNA) in maternal plasma is technically challenging due to the preponderance of maternal sequences. It has recently been shown that fetal cf‐DNA sequences are smaller than maternal ones and that the selection of small cf‐DNA fragments by size fractionation by agarose gel electrophoresis leads to the enrichment of fetal cf‐DNA sequences, thereby permitting the detection of otherwise masked fetal point mutations. In a separate development, the use of MALDI‐TOF MS has also been shown to facilitate the detection of fetal point mutations from cf‐DNA in maternal plasma. In this study, a combination of these approaches was examined. cf‐DNA was extracted from 18 maternal plasma samples, 10 taken at term and 8 obtained early in the second trimester. A total of 41 SNP loci were examined in size‐fractionated and total cf‐DNA using either a conventional homogeneous MassEXTEND® (hME) assay or a nucleotide‐specific single allele base extension reaction (SABER) assay. The analysis of total cf‐DNA indicated that size fractionation considerably enhanced the sensitivity of the standard hME assay, especially for samples taken early in pregnancy. Size fractionation also rendered the signals obtained by the SABER assay more precise.